• No results found

Human mesenchymal stromal cells : biological characterization and clinical application

N/A
N/A
Protected

Academic year: 2021

Share "Human mesenchymal stromal cells : biological characterization and clinical application"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Human mesenchymal stromal cells : biological characterization and clinical application

Bernardo, M.E.

Citation

Bernardo, M. E. (2010, March 4). Human mesenchymal stromal cells : biological

characterization and clinical application. Retrieved from https://hdl.handle.net/1887/15034

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/15034

Note: To cite this publication please use the final published version (if applicable).

(2)

249 LIST OF ABBREVIATIONS

AID autoimmune diseases

Array-CGH array-Comparative Genomic Hybridization AT adipose tissue

BM bone marrow CD Crohn’s Disease

CIA collagen-induced arthritis DC dendritic cell

DLI donor lymphocytes

EAE experimental autoimmune encephalomyelitis

EBMT European Group for Blood and Marrow Transplantation FCS fetal calf serum

G-CSF granulocyte colony stimulating factor GFs growth factors

GvHD graft-versus-host disease GvL graft-versus-leukemia HGF hepatocyte growth factor HSCs hematopoietic stem cells

HSCT hematopoietic stem cell transplantation IDO indoleamine 2,3-dioxygenase

MAPCs multipotent adult progenitor cells MLD metachromatic leukodystrophy MR magnetic resonance

MS multiple sclerosis MSCs mesenchymal stem cells NK Natural Killer

O.I. Osteogenesis Imperfecta PBSCT peripheral blood stem cell transplantation PGE2 prostaglandin E2

PL platelet-lysate PRP Platelet-rich plasma SDF-1 stromal-derived factor-1 SLE Systemic lupus erythematosus SS systemic sclerosis

SSEA-1 stage-specific embryonic antigen-1 TGF-β3 Transforming growth Factor-β3 Treg regulatory T cells

TRM transplantation-related mortality UCB umbical cord blood

USSCs Unrestricted Somatic Stem Cells

(3)

250

Referenties

GERELATEERDE DOCUMENTEN

MSCs from all donors were characterized by morphology, differentiation capacity and immune phenotype at different culture time points, namely P3, P6, P9, P12, P15 and later,

1 However, both primary (defined as lack of hematologic recovery or absence of donor chimerism) and secondary (defined as loss of donor chimerism after initial engraftment) 2

Patients with steroid-resistant, severe, acute GVHD were treated with mesenchymal stem cells, derived with the European Group for Blood and Marrow Transplantation ex-vivo

MSCs from bone marrow (BM) of 7 CD-patients (median age 32 years) were expanded ex vivo in the presence of 5% platelet lysate; cells were investigated for clonogenic

We also investigated the biological/functional properties of UCB-MSCs, in comparison with PL-expanded bone marrow (BM)-MSCs. Success rate of MSC isolation from UCB was in the order

However, at present, no specific marker or combination of markers has been identified that specifically defines true MSCs and ex vivo expanded cells are currently stained with

Hierbij is een vergelijking gemaakt tussen MSC’s afkomstig uit foetale weefsels, waaronder placenta en navelstrengbloed welke zijn vergeleken met MSC’s afkomstig uit het beenmerg

Based on these experimental and clinical findings and by broadening the knowledge on MSC biological activities, these cells could be employed in the near future as a